Lysergic acid and quinidine analogs. 2-(o-Acylaminophenethyl)piperidines.
D000813:Anilides / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D004873:Ergolines / Q000138:chemical synthesis* / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010880:Piperidines / Q000138:chemical synthesis*; D011802:Quinidine / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D012702:Serotonin Antagonists; D013035:Spasm / Q000517:prevention & control; D013329:Structure-Activity Relationship; D014599:Uterus / Q000187:drug effects
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D004873:Ergolines; D010880:Piperidines; D012702:Serotonin Antagonists; D011802:Quinidine